A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors
Janku, Filip, Javle, Milind M., Sen, Shiraj, Pant, Shubham, Bramwell, Lindsay G., Subbiah, Vivek, Way, Tracey, Wages, David S., Wheeler, Catherine A., Suzuki, Takeaki, Saeki, Kazunori, Subach, Ruth Ann, Madden, Timothy, Maier, Gary, Johansen, Mary J., Cheung, Kin, Falchook, Gerald S.
Published in Cancer (15.05.2023)
Published in Cancer (15.05.2023)
Get full text
Journal Article
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
Wu, Yi-Long, Park, Keunchil, Soo, Ross A, Sun, Yan, Tyroller, Karin, Wages, David, Ely, Guy, Yang, James Chih-Hsin, Mok, Tony
Published in BMC cancer (07.10.2011)
Published in BMC cancer (07.10.2011)
Get full text
Journal Article
Free omental tissue transfer for extremity coverage and revascularization
Maloney, Jr, Christopher T, Wages, David, Upton, Joseph, Lee, W P Andrew
Published in Plastic and reconstructive surgery (1963) (01.05.2003)
Published in Plastic and reconstructive surgery (1963) (01.05.2003)
Get more information
Journal Article
Optimizing independent finger flexion with zone V flexor repairs using the Massachusetts General Hospital flexor tenorrhaphy and early protected active motion
Wilhelmi, Bradon J, Kang, Robert H, Wages, David J, Lee, W P Andrew, May, Jr, James W
Published in The Journal of hand surgery (American ed.) (01.03.2005)
Published in The Journal of hand surgery (American ed.) (01.03.2005)
Get more information
Journal Article
A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors
Langer, Corey J., Curti, Brendan D., Farber, Charles Michael, Wheeler, Catherine A., Wages, David S., Matsumoto, Takeshi, Shimoyama, Susumu, Mori, Mikinaga, Yamada, Naoki, Subach, Ruth Ann, Madden, Timothy, Johansen, Mary, Maier, Gary, Cheung, Kin, Chaney, Marya F., Galsky, Matt D.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST)
Chawla, Sant P., Chua-Alcala, Victoria S., Sachdev, Jasgit C., Wages, David S., Stenehjem, David D., Santiesteban, Daniela Y., Mirza, Nadeem Q., Gordon, Michael S.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors
Matulonis, Ursula A., Janku, Filip, Moser, Justin C, Fu, Siqing, Wages, David S., Wheeler, Catherine A., Mori, Mikinaga, Shimoyama, Susumu, Yamada, Naoki, Subach, Ruth Ann, Cheung, Kin, Madden, Timothy, Maier, Gary, Johansen, Mary, Falchook, Gerald Steven
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas
Reed, Damon R., Chawla, Sant P., Setty, Bhuvana, Mascarenhas, Leo, Meyers, Paul A., Metts, Jonathan, Harrison, Douglas James, Lessnick, Stephen L., Crompton, Brian D., Loeb, David, Stenehjem, David D., Wages, David S., Santiesteban, Daniela Y., Mirza, Nadeem Q., DuBois, Steven G.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma
Reed, Damon R., Chawla, Sant P., Setty, Bhuvana, Mascarenhas, Leo, Meyers, Paul A., Metts, Jonathan, Harrison, Douglas James, Loeb, David, Crompton, Brian D., Wages, David S., Stenehjem, David D., Santiesteban, Daniela Y., Mirza, Nadeem Q., DuBois, Steven G.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Phase I expansion study of P-cadherin-targeted 90Y-FF-21101 antibody in advanced chemorefractory colorectal and pancreatic-biliary cancers
Mahalingam, Devalingam, Subbiah, Vivek, Owonikoko, Taofeek K., Ulahannan, Susanna Varkey, Richardson, Debra L., Kalyan, Aparna, Mulcahy, Mary Frances, Wheeler, Catherine A., Matsushima, Satoshi, Suzuki, Takeaki, Subach, Ruth Ann, Johansen, Mary, Madden, Timothy, Cheung, Kin, Wages, David S.
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma
Reed, Damon R., Mascarenhas, Leo, Meyers, Paul A., Chawla, Sant P., Harrison, Douglas James, Setty, Bhuvana, Metts, Jonathan, Wages, David S., Stenehjem, David D., Santiesteban, Daniela Y., DuBois, Steven G.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors
Subbiah, Vivek, Erwin, William, Mawlawi, Osama, McCoy, Asa, Wages, David, Wheeler, Catherine, Gonzalez-Lepera, Carlos, Liu, Holly, Macapinlac, Homer, Meric-Bernstam, Funda, Hong, David S., Pant, Shubham, Le, Dao, Santos, Elmer, Gonzalez, Jose, Roszik, Jason, Suzuki, Takeaki, Subach, Ruth Ann, Madden, Timothy, Johansen, Mary, Nomura, Fumiko, Satoh, Hirokazu, Matsuura, Tadashi, Kajita, Masamichi, Nakamura, Eri, Funase, Yuichi, Matsushima, Satoshi, Ravizzini, Gregory
Published in Clinical cancer research (15.11.2020)
Published in Clinical cancer research (15.11.2020)
Get full text
Journal Article
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
Smith, David A., Conkling, Paul, Richards, Donald A., Nemunaitis, John J., Boyd, Thomas E., Mita, Alain C., de La Bourdonnaye, Guillaume, Wages, David, Bexon, Alice S.
Published in Cancer Immunology, Immunotherapy (01.08.2014)
Published in Cancer Immunology, Immunotherapy (01.08.2014)
Get full text
Journal Article
Abstract CT100: First-in-human phase 1 trial of pyrimidine anti-metabolite FF-10502-01 in patients with advanced cancer
Falchook, Gerald Steven, Bramwell, Lindsay, Hannan, Lori, Vishwamitra, Deeksha, Yamada, Takayuki, Rosner, Michele, Wages, David, Myers, Thomas, Paradiso, Linda, Janku, Filip
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors
Janku, Filip, Sen, Shiraj, Pant, Shubham, Bramwell, Lindsay, Subbiah, Vivek, Way, Tracey, Javle, Milind M., Stone, Cassie, Prajapati, Bhumika, Hagiwara, Shinji, Johansen, Mary, Madden, Timothy, Maier, Gary, Subach, Ruth Ann, Saeki, Kazunori, Suzuki, Takeaki, Wages, David S., Wheeler, Catherine A., Falchook, Gerald Steven
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Preliminary Results from an Open-Label, Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia (CMML)
Patnaik, Mrinal M., Sallman, David A, Sekeres, Mikkael A., Luger, Selina, Bejar, Rafael, Hobbs, Gabriela S., DeZern, Amy E., Bolognese, James, Traynor, Mary, Mishra, Vishnu, Wages, David, Gualberto, Antonio, Scholz, Catherine, Padron, Eric
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article